Association of Extent and Aggressiveness of Inflammation with Serum PSA Levels and PSA Density in Asymptomatic Patients

Urology

Volumn 70, Issue 4, 2007, Pages 743-747

  Kandirali, Engin ^a   Boran, Cetin ^a   Serin, Erdinc ^a   Semercioz, Atilla ^a   Metin, Ahmet ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENEMA; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; DIGITAL RECTAL EXAMINATION; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; SERUM; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATITIS;

EID: 35648936434     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.06.1102     Document Type: Article

References (29)

1. Polascik T.J., Oesterling J.E., and Partin A.W. Prostate specific antigen: a decade of discovery-What we have learned and where we are going. J Urol 162 (1999) 293-306
2. Kawakami J., Siemens D.R., and Nickel J.C. Prostatitis and prostate cancer: implications for prostate cancer screening. Urology 64 (2004) 1075-1080
3. Brawn P.N., Speights V.O., Kuhl D., et al. Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates. Cancer 68 (1991) 1592-1599
4. Irani J., Levillain P., Goujon J.M., et al. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 157 (1997) 1301-1303
5. Schatteman P.H., Hoekx L., Wyndaele J.J., et al. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 37 (2000) 404-412
6. Yaman O., Gogus C., Tulunay O., et al. Increased prostate-specific antigen in subclinical prostatitis: the role of the aggressiveness and extension of inflammation. Urol Int 71 (2003) 160-164
7. Simardi L.H., Tobias-MacHado M., Kappaz G.T., et al. Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study. Urology 64 (2004) 1098-1101
8. Kwak C., Ku J.H., Kim T., et al. Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology 62 (2003) 854-859
9. Terris M.K., and Stamey T.A. Determination of prostate volume by transrectal ultrasound. J Urol 145 (1991) 984-987
10. Mettlin C.J., Murphy G.P., Ho R., et al. The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer 15 (1996) 2162-2166
11. Fleshner N.E., O'Sullivan M., and Fair W.R. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 158 (1997) 505-508
12. Morote J., Lopez M., Encabo G., et al. Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 37 (2000) 537-540
13. Ornstein D.K., Smith D.S., Humphrey P.A., et al. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol 159 (1998) 1234-1237
14. Jung K., Meyer A., Lein M., et al. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 159 (1998) 1595-1598
15. Stancik I., Luftenegger W., Klimpfinger M., et al. Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 46 (2004) 760-764
16. Minardi D., Galosi A.B., Recchioni A., et al. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients. Urol Int 67 (2001) 272-282
17. Scattoni V., Raber M., Montorsi F., et al. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Eur Urol 36 (1999) 621-630
18. Culig Z., Steiner H., Bartsch G., et al. Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 95 (2005) 497-505
19. Mistry T., Digby J.E., Desai K.M., et al. Obesity and prostate cancer: a role for adipokines. Eur Urol 52 (2007) 46-53
20. Wise G.J., Marella V.K., Talluri G., et al. Cytokine variations in patients with hormone treated prostate cancer. J Urol 164 3 Pt 1 (2000) 722-725
21. Chang S.G., Kim C.S., Jeon S.H., et al. Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer?. Int J Urol 13 (2006) 122-126
22. Giovannucci E. Medical history and etiology of prostate cancer. Epidemiol Rev 23 (2001) 159-162
23. Platz E.A., and De Marzo A.M. Epidemiology of inflammation and prostate cancer. J Urol 171 2 Pt 2 (2004) S36-S40
24. Dennis L.K., Lynch C.F., and Torner J.C. Epidemiologic association between prostatitis and prostate cancer. Urology 60 (2002) 78-83
25. Lucia M.S., and Torkko K.C. Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale. J Urol 171 2 Pt 2 (2004) S30-S34
26. Jang T.L., and Schaeffer A.J. The role of cytokines in prostatitis. World J Urol 21 (2003) 95-99
27. Kramer G., Mitteregger D., and Marberger M. Is benign prostatic hyperplasia (BPH) an i{dotless}mmune i{dotless}nflammatory disease?. Eur Urol 51 (2007) 1202-1216
28. Steiner G.E., Newman M.E., Paikl D., et al. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56 (2003) 171-182
29. Stephan C., Xu C., Brown D.A., et al. Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network. Prostate 66 (2006) 651-659